Maze Therapeutics, Inc. (MAZE) — S-1 Filings
All S-1 filings from Maze Therapeutics, Inc.. Browse 2 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (2)
-
Maze Therapeutics S-1 Signals Resale of $150M Private Placement Shares
— Oct 17, 2025 Risk: high
Maze Therapeutics, Inc. (MAZE) filed an S-1 on October 17, 2025, for the resale of up to 9,231,092 shares of common stock by selling stockholders, following a p -
Maze Therapeutics Files S-1 for Public Offering
— Jan 7, 2025 Risk: medium
Maze Therapeutics, Inc., incorporated in Delaware, filed an S-1 registration statement on January 7, 2025. The company, located at 171 Oyster Point Boulevard, S
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX